QNRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Quoin Pharmaceuticals Ltd (QNRX).


$4.84M Market Cap.

As of 03/14/2024 5:00 PM ET (MRY) • Disclaimer

QNRX Market Cap. (MRY)


QNRX Shares Outstanding (MRY)


QNRX Assets (MRY)


Total Assets

$12.17M

Total Liabilities

$6.51M

Total Investments

$8.29M

QNRX Income (MRY)


Revenue

$0

Net Income

-$8.69M

Operating Expense

$9.38M

QNRX Cash Flow (MRY)


CF Operations

-$7.86M

CF Investing

$2.19M

CF Financing

$5.22M

QNRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

-

-

2022

$0

0%

0%

-

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

QNRX Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$12,169,229 (-15.83%)

$14,458,063 (54.52%)

$9,356,851 (579.11%)

$1,377,818 (-79.06%)

Assets Current

$11,285,895 (-15.59%)

$13,370,112 (63.09%)

$8,198,247 (1662.42%)

$465,170 (-91.89%)

Assets Non-Current

$883,334 (-18.81%)

$1,087,951 (-6.10%)

$1,158,604 (26.95%)

$912,648 (7.72%)

Goodwill & Intangible Assets

$583,334 (-17.21%)

$704,561 (-12.87%)

$808,604 (-11.40%)

$912,648 (0%)

Shareholders Equity

$5,664,016 (-23.53%)

$7,406,774 (1027.31%)

$657,032 (109.94%)

-$6,607,297 (-244.29%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$2,401,198 (-16.06%)

$2,860,628 (-61.77%)

$7,482,773 (2210.70%)

$323,832 (-94.21%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$8,293,663 (-17.00%)

$9,992,900 (0%)

$0 (0%)

$0 (0%)

Investments Current

$8,293,663 (-17.00%)

$9,992,900 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$526,523 (-13.06%)

$605,600 (-34.40%)

$923,239 (-81.12%)

$4,888,913 (389.20%)

Accumulated Retained Earnings (Deficit)

-$46,203,320 (-23.15%)

-$37,516,747 (-33.65%)

-$28,069,985 (-324.83%)

-$6,607,397 (78.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$0 (0%)

$1,213,313 (266.37%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$1,213,313 (892.72%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$6,505,213 (-7.74%)

$7,051,289 (-18.95%)

$8,699,819 (8.95%)

$7,985,115 (299.07%)

Liabilities Current

$3,581,480 (1.53%)

$3,527,556 (-22.91%)

$4,576,087 (-42.69%)

$7,985,115 (611.94%)

Liabilities Non-Current

$2,923,733 (-17.03%)

$3,523,733 (-14.55%)

$4,123,732 (0%)

$0 (0%)

QNRX Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$6,070,517 (-7.81%)

$6,584,868 (46.33%)

$4,499,923 (215.59%)

$1,425,855 (-5.87%)

Research & Development Expense

$3,307,987 (23.76%)

$2,672,836 (71.01%)

$1,562,927 (540.14%)

$244,155 (434.84%)

Operating Expenses

$9,378,504 (1.30%)

$9,257,704 (52.70%)

$6,062,850 (263.04%)

$1,670,010 (7.02%)

Interest Expense

$0 (0%)

$714,081 (-47.70%)

$1,365,409 (2803.83%)

$47,021 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

-$2,095,364 (-34.28%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

-$2,095,364 (-34.28%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

-$2,095,364 (-34.28%)

Weighted Average Shares

$987,220 (144.43%)

$403,884 (1434.69%)

$26,317 (31.43%)

$20,024 (0.00%)

Weighted Average Shares Diluted

-

-

$26,317 (31.43%)

$20,024 (0.00%)

Earning Before Interest & Taxes (EBIT)

-$8,686,573 (-0.22%)

-$8,667,415 (56.87%)

-$20,097,179 (-881.14%)

-$2,048,343 (-31.27%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$9,378,504 (-1.30%)

-$9,257,704 (-52.70%)

-$6,062,850 (-263.04%)

-$1,670,010 (-7.02%)

QNRX Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$2,188,316 (121.56%)

-$10,149,121 (-1523.86%)

-$625,000 (-400.00%)

-$125,000 (0%)

Net Cash Flow from Financing

$5,216,683 (-62.76%)

$14,007,708 (3.73%)

$13,504,031 (655.49%)

$1,787,465 (37.62%)

Net Cash Flow from Operations

-$7,864,429 (7.27%)

-$8,480,732 (-48.26%)

-$5,720,090 (-327.31%)

-$1,338,633 (-3.06%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$459,430 (90.06%)

-$4,622,145 (-164.56%)

$7,158,941 (2110.70%)

$323,832 (809680.00%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$2,188,316 (122.11%)

-$9,899,121 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$250,000 (60.00%)

-$625,000 (-400.00%)

-$125,000 (0%)

Issuance (Repayment) of Debt Securities

-$632,583 (30.61%)

-$911,669 (-128.75%)

$3,170,534 (268.68%)

$859,980 (0%)

Issuance (Purchase) of Equity Shares

$5,849,266 (-60.68%)

$14,877,332 (47.26%)

$10,102,874 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,094,549 (43.26%)

$764,007 (0%)

$0 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$103,706 (-0.32%)

$104,043 (0.00%)

$104,043 (0.00%)

$104,043 (402.38%)

QNRX Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-105.10% (64.49%)

-296.00% (-141.03%)

721.40% (1216.72%)

-64.60% (-146.56%)

Return on Average Assets (ROAA)

-55.70% (37.56%)

-89.20% (77.69%)

-399.90% (-1141.93%)

-32.20% (-86.13%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-118.10% (70.33%)

-398.00% (-200.40%)

396.40% (186.83%)

138.20% (113.00%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-

-

-0.46 (-1367.74%)

-0.03 (27.91%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.85 (-7.97%)

0.93 (-95.98%)

23.13 (1909.86%)

-1.28 (-217.68%)

Debt to Equity Ratio (D/E)

1.15 (20.69%)

0.95 (-92.81%)

13.24 (1195.20%)

-1.21 (-376.66%)

Earnings Per Share (EPS)

-

-

-600 (98.57%)

-41,999.99 (-34.62%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-7.97 (63.15%)

-21.62 (91.03%)

-241.1 (-229.86%)

-73.09 (-12.69%)

Book Value Per Share (BVPS)

5.74 (-68.72%)

18.34 (-26.54%)

24.97 (107.57%)

-329.96 (-244.29%)

Tangible Assets Book Value Per Share (TABVPS)

11.74 (-65.54%)

34.05 (-89.52%)

324.82 (1298.28%)

23.23 (-92.93%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (0.00%)

-1 (-200.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.2 (-2.62%)

-0.19 (81.60%)

-1.04 (10.75%)

-1.16 (-227.80%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.15 (-16.86%)

3.79 (111.50%)

1.79 (2989.66%)

0.06 (-98.87%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$7,864,429 (9.92%)

-$8,730,732 (-37.60%)

-$6,345,090 (-333.52%)

-$1,463,633 (-12.69%)

Enterprise Value (EV)

$1,678,888 (2.85%)

$1,632,376 (-92.14%)

$20,757,585 (818.10%)

$2,260,933 (261.32%)

Earnings Before Tax (EBT)

-$8,686,573 (7.41%)

-$9,381,496 (56.29%)

-$21,462,588 (-924.29%)

-$2,095,364 (-34.28%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$8,582,867 (-0.23%)

-$8,563,372 (57.17%)

-$19,993,136 (-928.29%)

-$1,944,300 (-26.28%)

Invested Capital

$5,603,217 (-23.92%)

$7,365,318 (309.80%)

-$3,510,613 (47.05%)

-$6,630,464 (-3389.87%)

Working Capital

$7,704,415 (-21.72%)

$9,842,556 (171.73%)

$3,622,160 (148.17%)

-$7,519,945 (-263.07%)

Tangible Asset Value

$11,585,895 (-15.76%)

$13,753,502 (60.89%)

$8,548,247 (1737.66%)

$465,170 (-92.93%)

Market Capitalization

$4,842,314 (-29.64%)

$6,882,208 (-54.71%)

$15,197,064 (79.96%)

$8,444,535 (69.77%)

Average Equity

$8,266,007 (160.82%)

$3,169,230 (206.52%)

-$2,975,132 (-191.69%)

$3,244,672 (-45.53%)

Average Assets

$15,599,314 (48.39%)

$10,512,215 (95.86%)

$5,367,334 (-17.61%)

$6,514,863 (-27.91%)

Invested Capital Average

$7,355,600 (237.80%)

$2,177,505 (142.94%)

-$5,070,538 (-242.18%)

-$1,481,846 (-1109.19%)

Shares

987,220 (144.43%)

403,884 (625.54%)

55,667 (754.31%)

6,516 (74.46%)